TURKU, FI / ACCESS Newswire / May 27, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - New preclinical data published in Scientific Reports confirms CLEVER-1 inhibition by Bexmarilimab increases a ...

The primary endpoint was recurrence-free survival (RFS), and secondary endpoints included overall survival (OS), as well as biomarker analysis (ctDNA, interferon gamma [IFNG] gene expression and ...

SK Telecom announced on the 17th that it has demonstrated next-generation virtualized base stations, a key technology for upgrading mobile communication networks, in a commercial environment in ...

IL-2 stimulation post-transcriptionally enhances splicing of IFNG mRNA in NK cells. Further, NF-κB signaling downstream of the IL-2 receptor is required for IFNG mRNA processing. IL-12 and IL-2 ...

Claudin18.2-targeted chimeric antigen receptor T cell-therapy for patients with gastrointestinal cancers: Final results of CT041-CG4006 phase 1 trial. This is an ASCO Meeting Abstract from the 2024 ...

The study identifies a risk-scoring model involving four ICD-related genes (CALR, IL1R1, IFNB1, IFNG), showing a correlation between higher risk scores and weaker anti-tumor immune function. Strengths ...

The high ICD group responded better to PD1-targeted therapy. A risk-scoring model with four ICD-related genes (CALR, IL1R1, IFNB1, IFNG) was validated across TCGA, GEO datasets, and tissue samples, ...

In the B16F10 melanoma model, a single dose of SON-1010 results in a marked reduction of tumor growth that was concomitant with increased IFNg, along with augmented immune cell numbers and activity in ...

The differential response to immune checkpoint inhibitors (ICIs) according to mismatch repair alterations in gastrointestinal (GI) non-colorectal cancers (non-CRCs) and the impact of dual vs.

Researchers from Cytimmune Sciences, a clinical-stage biotech company, have presented new data on the company’s novel cancer nanomedicines. The presentation took place at the Cytokine Drug Development ...